Sarah Connors joined Kronos Bio in April 2023 as Vice President of Investor Relations and Corporate Communications. Prior to joining Kronos, Sarah served as Vice President of Corporate Communications and Patient Advocacy at Karyopharm Therapeutics. Previously, Sarah was the Head of U.S. Communications at Oncopeptides and Executive Director of Corporate Communications at AMAG Pharmaceuticals. Earlier in her career, Sarah spent 10 years at Sanofi Genzyme in a series of communications roles of increasing responsibility across multiple divisions including oncology and immunology. She serves on the Board of Directors and Governance Committee for Women’s Money Matters. Sarah received her B.A. in English from the College of the Holy Cross and her M.B.A. with a focus in health sector management from Boston University.